Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver X Receptor Beta (LXRβ) is a nuclear receptor transcription factor that plays a crucial role in lipid metabolism, cholesterol homeostasis, and immune response. Unlike LXRα, which is primarily expressed in metabolically active tissues, LXRβ is ubiquitously expressed. It forms a heterodimer with RXRα and, upon ligand binding, regulates the expression of genes involved in cholesterol absorption, transport, and efflux, as well as fatty acid metabolism. Its implication in diseases like atherosclerosis, amyotrophic lateral sclerosis, and chronic pancreatitis makes it a potential therapeutic target.
LXRβ forms a heterodimer with RXRα. Upon binding with ligands like oxysterols or synthetic agonists, the heterodimer binds to LXR response elements (LXREs) on DNA, leading to the recruitment of coactivators and increased transcription of target genes involved in lipid metabolism, cholesterol transport, and fatty acid metabolism. In the absence of ligand, the complex recruits corepressors, repressing gene expression. It regulates uptake through MYLIP-dependent ubiquitination pathways affecting LDLR/VLDLR/LRP8 receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver X Receptor Beta (LXRβ).